Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sen. Hatch on retail prices

Executive Summary

Utah Republican issues Aug. 10 statement retracting an earlier criticism of "excessive" retail markups. During the March Senate debate on Sen. Pryor's (D-Ark.) S 2000 ("The Pink Sheet" March 16, p. 3), "I inadvertently made a one-sentence statement that implied that one of the causes of drug price increases was excessive markup at the retail and wholesale level," Hatch explains. "In the heat of a spirited debate, I misspoke." Hatch adds: "I understand the increasing pressures on drug wholesaler and retailers as they strive to remain successful in today's often difficult economic environment."

Latest Headlines
See All
UsernamePublicRestriction

Register

PS021381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel